Candriam SCA’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-62,007
| Closed | -$6.32M | – | 829 |
|
|
2019
Q2 | $6.32M | Buy |
62,007
+3,007
| +5% | +$306K | 0.08% | 277 |
|
|
2019
Q1 | $6.72M | Sell |
59,000
-100
| -0.2% | -$11.4K | 0.09% | 262 |
|
|
2018
Q4 | $2.31M | Hold |
59,100
| – | – | 0.04% | 427 |
|
|
2018
Q3 | $3.22M | Buy |
59,100
+28,700
| +94% | +$1.57M | 0.04% | 408 |
|
|
2018
Q2 | $2.52M | Buy |
+30,400
| New | +$2.52M | 0.04% | 437 |
|
|
2017
Q4 | – | Sell |
-55,000
| Closed | -$4.9M | – | 786 |
|
|
2017
Q3 | $4.9M | Buy |
55,000
+28,000
| +104% | +$2.5M | 0.09% | 268 |
|
|
2017
Q2 | $1.61M | Hold |
27,000
| – | – | 0.03% | 501 |
|
|
2017
Q1 | $1.44M | Sell |
27,000
-9,000
| -25% | -$480K | 0.03% | 500 |
|
|
2016
Q4 | $1.8M | Buy |
36,000
+11,000
| +44% | +$549K | 0.04% | 391 |
|
|
2016
Q3 | $1.5M | Sell |
25,000
-29,000
| -54% | -$1.74M | 0.04% | 414 |
|
|
2016
Q2 | $2.76M | Buy |
54,000
+24,000
| +80% | +$1.23M | 0.07% | 262 |
|
|
2016
Q1 | $881K | Sell |
30,000
-10,000
| -25% | -$294K | 0.02% | 451 |
|
|
2015
Q4 | $1.81M | Buy |
+40,000
| New | +$1.81M | 0.05% | 313 |
|
|
2015
Q3 | – | Sell |
-60,000
| Closed | -$3.62M | – | 656 |
|
|
2015
Q2 | $3.62M | Buy |
60,000
+5,000
| +9% | +$301K | 0.08% | 284 |
|
|
2015
Q1 | $4.26M | Buy |
+55,000
| New | +$4.26M | 0.09% | 278 |
|